Navigation Links
A Better Acetabular Solution from StelKast ... Naturally
Date:4/15/2011

MCMURRAY, Pa., April 15, 2011 /PRNewswire/ -- StelKast is proud to announce the recent FDA 510(k) clearance of their new EXp™ Acetabular Liners. EXp™, a blend of antioxidant and highly cross-linked polyethylene technology was developed with the consulting support of Steven Kurtz, Ph.D. and Exponent, Inc. (Philadelphia, PA). StelKast has also received 510(k) clearance for large diameter cobalt-chrome femoral heads and Biolox® delta femoral heads.

(Logo:  http://photos.prnewswire.com/prnh/20110415/LA83876LOGO)

Mr. Peter Stephans, Chairman & CEO, said in a statement, "EXp™ polyethylene technology represents an optimal blend of UHMWPE, the antioxidant vitamin E (alpha-tocopherol), and cross-linking for long-term oxidative stability, preservation of mechanical properties and performance. Unlike other highly cross-linked materials, EXp™ polyethylene requires no thermal processing or infusion of antioxidants to stabilize the material. The combination of EXp™ Acetabular Liners and large diameter heads promotes joint stability.

"StelKast is excited to be the first US orthopedic company to provide a highly crosslinked vitamin E blended acetabular system offering superior oxidation resistance. The introduction of EXp™ polyethylene is just another example of StelKast's commitment to place emerging technology and high quality implants in surgeon's hands through cost effective solutions."

Full commercial launch of the EXp™ Acetabular System is planned for July 2011. For inquiries, please contact your local StelKast representative or Customer Service at 888-273-1583.

StelKast specializes in the design, manufacture, and distribution of hip and knee implant systems. The Company's mission is to provide high-quality, cost effective solutions to meet the challenges of the orthopedic community through clinically proven design
'/>"/>

SOURCE StelKast Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
2. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
3. Organ Donor Shortage Remains Obstacle for Would-Be Transplant Patients Despite Better Medicine
4. Research Presented at ISHLT Shows Promise of Addressing Critical Organ Shortage and Better Organ Preservation
5. Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
6. Phreesia Announces Clinical Initiative to Better Manage Symptoms of Parkinsons Disease
7. In Blood Vessel Stents, Innovative Materials Allow Better Control, Delivery of Gene Therapy
8. Study in JAMA Shows Patients Treated With Abbotts XIENCE(TM) V Drug Eluting Stent Experience Better Outcomes Than Patients Treated With Market-Leading Drug Eluting Stent
9. Patients With Asthma and Seasonal Allergies Respond Better to Advair(R) for Their Asthma Than Singulair(TM)
10. Halozyme Therapeutics Announces Phase I Clinical Trial Results Demonstrating that the Combination of Recombinant Human Hyaluronidase (rHuPH20) With Humulin R(R) and with Humalog(R) Yields Faster, More Physiologic Insulin Kinetics and Better Predictability
11. Data Presented at Annual Meeting of Japanese Society of Interventional Cardiology Demonstrate OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) Has Better Outcomes When Compared to Drug-Eluting Stents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... NEWARK, Calif. , July 29, 2015 /PRNewswire/ ... "Company") today announced that its Board of Directors, ... its independent financial and legal advisors, has unanimously ... non-binding proposal from Horizon Pharma plc (NASDAQ: ... outstanding shares of Depomed in an all-stock transaction ...
(Date:7/29/2015)... July 29, 2015 Alvarado Hospital unveiled ... the Alvarado Spine & Joint Institute. The institute ... focusing on spinal surgery and joint replacement. The ... takes a patient experience-focused approach. For example, patients ... comfortable in, rather than patient gowns. ...
(Date:7/29/2015)... FOREST, Calif. , July 29, 2015 ... ("Cryoport" or the "Company"), the leading provider ... life sciences industry, serving markets including immunotherapies, ... vaccine manufacturers, animal health, and reproductive medicine, ... the sale of common stock and warrants (the ...
Breaking Medicine Technology:Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 2Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 3Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 4Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 5Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 6Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 7Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 8Depomed's Board of Directors Unanimously Rejects Purported Revised, Highly Conditional, Unsolicited Proposal from Horizon Pharma plc 9The Alvarado Spine & Joint Institute Opens July 30 in San Diego 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3
... May 21, 2010 , , ... - Europe,s Leading Stem Cell Bank Launches Innovative Service for,Liposuction Market ... Cryo-Save today announced the ... a rich mixture,of adult stem cells from liposuction aspirate (fatty tissue that is normally,discarded). ...
... DIEGO , May 21 Sorrento Therapeutics, ... has received an Advanced Technology Small Business Technology Transfer ... and Infectious Diseases. The peer-reviewed grant was awarded to ... antibody therapeutics and vaccines to combat Staphylococcus aureus ...
Cached Medicine Technology:Cryo-Storage of Adult Stem Cells From Fat 2Cryo-Storage of Adult Stem Cells From Fat 3Sorrento Therapeutics Awarded NIH Grant for MRSA Program 2